Monoacylglycerol lipase contributes to pathogenesis of Alzheimer's disease

Monoacylglycerol lipase contributes to pathogenesis of Alzheimer's disease

Alzheimer’s disease (AD) is the most common cause of dementia among older people. There are no effective medications currently available to prevent and treat AD and halt disease progression. Monoacylglycerol lipase (MAGL) is the primary enzyme metabolizing the endocannabinoid 2-arachidonoylglycerol...

Full description

Bibliographic Details
Main Authors:	Chen, Rongqing, Zhang, Jian, Wu, Yan, Wang, Dongqing, Feng, Guoping, Tang, Ya-Ping, Chen, Chu
Other Authors:	Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Format:	Article
Published:	Elsevier 2017
Online Access:	http://hdl.handle.net/1721.1/112276 https://orcid.org/0000-0002-8021-277X

Similar Items

Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
by: Chen, Rongqing, et al.
Published: (2014)

Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
by: Pimplikar, Sanjay W., et al.
Published: (2015)

Recent progress on the role of GABAergic neurotransmission in the pathogenesis of Alzheimer’s disease
by: Abbas, G., et al.
Published: (2016)

Polyamine pathway contributes to the pathogenesis of Parkinson disease
by: Lewandowski, Nicole M., et al.
Published: (2014)

Optimisation of Enzymatic Methanolysis of Indonesian Palm Oil to Produce Monoacylglycerols
by: , Teuku Beuna Bardant, Kiky Corneliasari Sembiring, Achmad Hanafi
Published: (2007)

Distinct contribution of white matter damage to the clinical syndrome of Alzheimer's disease
by: Coutu, Jean-Philippe
Published: (2016)

Neddylation dysfunction in Alzheimer's disease
by: Chen, Yuzhi, et al.
Published: (2014)

Pathogenesis and management of Buerger's disease
by: Liew, Ngoh Chin, et al.
Published: (2015)

The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis
by: Zhou, Zhi Dong, et al.
Published: (2023)

Alzheimer's disease talk
by: The Star,
Published: (2012)

Tienma and Alzheimer's disease
by: Huang, Junjie
Published: (2013)

Folding simulation of amyloid β-peptide in alzheimer's disease.
by: Koh, Jessica Li Jian.
Published: (2010)

Altered gut microbial metabolites in amnestic mild cognitive impairment and alzheimer's disease : signals in host-microbe interplay
by: Wu, Li, et al.
Published: (2021)

Phosphoproteomics analysis of Alzheimer's disease
by: Morshed, Nader Francis.
Published: (2021)

Brain macrophages in Alzheimer's disease: from ontogeny to function
by: Wu, Xiaoting
Published: (2024)

Editorial: molecular pathogenesis of tropical veterinary diseases
by: Othman, Sarah, et al.
Published: (2023)

Sodium Silicate Catalyst for Synthesis Monoacylglycerol and Diacylglycerol-Rich Structured Lipids: Product Characteristic and Glycerolysis–Interesterification Kinetics
by: Wangi, Inasanti Pandan, et al.
Published: (2022)

Integrated computational and experimental analysis of non-neuronal cell molecular mechanisms contributing to Alzheimer's disease progression
by: Lee, Meelim Jasmine
Published: (2024)

Molecular pathogenesis of Helicobacter hepaticus induced liver disease
by: Boutin, Samuel R., 1952-
Published: (2007)

Diagnosis and management of Alzheimer's disease--an update
by: Srinivas, P.
Published: (1999)

Spatial coding in aging and Alzheimer's disease
by: Fang, Yue
Published: (2023)

Alzheimer’s disease : a panorama glimpse
by: Zhao, Li Na, et al.
Published: (2014)

Amyloid fibril formation in Alzheimer's disease
by: Jarrett, Joseph Timothy
Published: (2012)

Apiary- an engaging cognitive stimulation toolkit for Singaporean Alzheimer's disease patients
by: Tang, Ik Hwa
Published: (2022)

Age-related eye diseases in individuals with mild cognitive impairment and Alzheimer's disease
by: Chua, Jacqueline, et al.
Published: (2022)

The role, involvement and function(s) of interleukin-35 and interleukin-37 in disease pathogenesis
by: Bello, Ramatu Omenesa, et al.
Published: (2018)

Reduction of mNAT1/hNAT2 contributes to cerebral endothelial necroptosis and Aβ accumulation in alzheimer's disease
by: Zou, Chengyu, et al.
Published: (2021)

Infection processes and pathogenesis mechanism of Fusarium proliferatum in Bakanae disease
by: Quazi, Shireen Akhter Jahan
Published: (2014)

An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease
by: Zahari Sham, Siti Yazmin, et al.
Published: (2022)

Memory, ageing and Alzheimer's disease: the case for Malaysia
by: Dzulkifli, Mariam Adawiah
Published: (2012)

Anatomical analysis of brain MRI in Alzheimer’s disease
by: Farzan, Ali, et al.
Published: (2014)

Alzheimer's disease: undiagnosed due to lack of awareness
by: Roslan, Muhammad Basir
Published: (2020)

Diverse pathways to neuronal necroptosis in Alzheimer's disease
by: Jayaraman, Anusha, et al.
Published: (2022)

Magnetic nanoparticles as in vivo tracers for Alzheimer’s disease
by: Sharma, Bhargy, et al.
Published: (2020)

Mitochondrial regulation of microglial immunometabolism in Alzheimer’s disease
by: Fairley, Lauren H., et al.
Published: (2021)

Development of point-of-care product for alzheimer's disease
by: Oktavina, Shellia
Published: (2022)

Glutamate Receptors in Alzheimer’s Disease: Mechanisms and Therapies
by: Anggono, Victor, et al.
Published: (2016)

White matter connectivity for detection of Alzheimer's disease
by: Huang, Dajing
Published: (2017)

Harnessing cerebral organoids for Alzheimer's disease research
by: Bubnys, Adele, et al.
Published: (2023)

Behaviorally defined subgroups of patients with Alzheimer's disease
by: Freed, David Matthew
Published: (2005)